Invest in ME have now raised £57,000 for their UK rituximab trial from a variety of organisations and individuals and can begin the first phase.
The UCL team is working on a study to confirm and expand Dr Bansal’s B cell results in a different cohort of ME patients. IiME’s advisor, Professor Jonathan Edwards, will be consulting with Norwegian researchers Professor Olav Mella and Dr Oystein Fluge about their trial.
The £350,000 trial is being funded through the ‘Matrix project’. 100 people or organisations are invited to contribute by pledging to raise or donate £1,000 each.